Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

CNTX Context Therapeutics Inc

1,98

0,00 (0,00%)

Vor Marktöffnung

Zuletzt aktualisiert: 11:53:26

Verzögert um 15 Minuten

Form D - Notice of Exempt Offering of Securities

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
Von Mai 2024 bis Jun 2024

Click Here for more Context Therapeutics Charts.

Context Therapeutics (NASDAQ:CNTX)
Historical Stock Chart
Von Jun 2023 bis Jun 2024

Click Here for more Context Therapeutics Charts.

News Context Therapeutics Inc

Form EFFECT - Notice of Effectiveness
Montag 3 Juni 2024 (7 Stunden vor) • Edgar (US Regulatory)

Form 424B3 - Prospectus [Rule 424(b)(3)]
Freitag 31 Mai 2024 (3 Tage vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Freitag 24 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form S-3 - Registration statement under Securities Act of 1933
Freitag 24 Mai 2024 (1 Woche vor) • Edgar (US Regulatory)

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Freitag 10 Mai 2024 (3 Wochen vor) • Edgar (US Regulatory)

Context Therapeutics Reports First Quarter 2024 Operating and Financial Results
Mittwoch 8 Mai 2024 (4 Wochen vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 8 Mai 2024 (4 Wochen vor) • Edgar (US Regulatory)

Context Therapeutics Announces FDA Clearance of IND Application for a Phase 1 Clinical Trial of CTIM-76
Donnerstag 2 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Context Therapeutics Announces $100 Million Private Placement
Donnerstag 2 Mai 2024 (1 Monat vor) • GlobeNewswire Inc.

Context Therapeutics Submits IND Application to Evaluate CTIM-76 in Claudin 6-Positive Cancers
Montag 1 April 2024 (2 Monate vor) • GlobeNewswire Inc.

Context Therapeutics Reports Full Year 2023 Operating and Financial Results
Donnerstag 21 März 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Mittwoch 6 März 2024 (3 Monate vor) • Edgar (US Regulatory)

Weitere Context Therapeutics Inc News-Artikel

Ivz Wld Pfhdg D

Exchange Traded Funds

SG Issuer Sg Issuer Mc M...

Pepper I Prime 2017 3

Vang VJPN iNvav

Vontobel Financial Produ...

BNP PARIBAS ISSUANCE

SG Issuer Sg Issuer Mc F...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen